NasaPharm
Board
1 director, since incorporationSole director
appointed by deed of 27-01-2025
term without a fixed end
listed in the 2025 annual accounts, filed on 09-07-2026
Mandates through the years
1 name, the dashed line is todaySole director
Board
Mandates as a list
-
- Sole director, appointed by deed of 27-01-2025, still in office
Control
Founders
, ,
and 2 others
This company
NasaPharm
Equity -€21,265
Loss €46,265 in 2025
Capital
- Contribution
- €25,000
- Shares
- 100
- Contribution per share
- €250
- Equity per share
- -€213 in 2025
- Source
- 2025 annual accounts
Articles of association
deed of 27-01-2025 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Statutory auditorA statutory auditor is a registered auditor who checks the annual accounts. Small companies need not have one.
- No statutory auditor
Shareholders
At incorporation
deed of 27-01-2025 ↗
- 20 shares (20%) · €5,000
- 30 shares (30%) · €7,500
- 20 shares (20%) · €5,000
- 10 shares (10%) · €2,500
- 20 shares (20%) · €5,000